In contrast, participants in the placebo group lost an average of 2.2% of their body weight (2.5 kg) during the 80-week period
(7) New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation. American Diabetes Association, 2025
These medications bind to the same receptors as natural incretins but last for hours or days instead of minutes
The report includes an executive summary and a comprehensive overview of market drivers, restraints, opportunities, and challenges (DROC), along with insights into regulatory standards
Furthermore, Retatrutides potential role in addressing PCOS underscores the diverse applications of this medication, a testament to the pioneering efforts of Polypeptide.ltd
1 This trial demonstrated clinically meaningful reductions in body weight after 68 weeks of treatment